Modifying mesoporous silica nanoparticles to avoid the metabolic deactivation of 6-mercaptopurine and methotrexate in combinatorial chemotherapy
W Wang, C Fang, X Wang, Y Chen, Y Wang, W Feng… - Nanoscale, 2013 - pubs.rsc.org
Mesoporous silica nanoparticles with amino and thiol groups (MSNSN) were prepared and
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP–MSNSN–MTX. In …
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP–MSNSN–MTX. In …
Modifying mesoporous silica nanoparticles to avoid the metabolic deactivation of 6-mercaptopurine and methotrexate in combinatorial chemotherapy
W Wang, C Fang, X Wang, Y Chen, Y Wang… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Mesoporous silica nanoparticles with amino and thiol groups (MSNSN) were prepared and
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP-MSNSN-MTX. In …
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP-MSNSN-MTX. In …
[PDF][PDF] Modifying mesoporous silica nanoparticles to avoid the metabolic deactivation of 6-mercaptopurine and methotrexate in combinatorial chemotherapy
W Wang, C Fang, X Wang, Y Chen, Y Wang, W Feng… - Nanoscale, 2013 - researchgate.net
Mesoporous silica nanoparticles with amino and thiol groups (MSNSN) were prepared and
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP–MSNSN–MTX. In …
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP–MSNSN–MTX. In …
Modifying mesoporous silica nanoparticles to avoid the metabolic deactivation of 6-mercaptopurine and methotrexate in combinatorial chemotherapy
W Wang, C Fang, X Wang, Y Chen, Y Wang… - …, 2013 - ui.adsabs.harvard.edu
Mesoporous silica nanoparticles with amino and thiol groups (MSNSN) were prepared and
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP-MSNSN-MTX. In …
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP-MSNSN-MTX. In …
Modifying mesoporous silica nanoparticles to avoid the metabolic deactivation of 6-mercaptopurine and methotrexate in combinatorial chemotherapy.
W Wang, C Fang, X Wang, Y Chen, Y Wang, W Feng… - Nanoscale, 2013 - europepmc.org
Mesoporous silica nanoparticles with amino and thiol groups (MSNSN) were prepared and
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP-MSNSN-MTX. In …
covalently modified with methotrexate and 6-mercaptopurine to form 6-MP-MSNSN-MTX. In …